FIBROCELL SCIENCE INC COMMON (FCSC) Covered Calls

Fibrocell Science Inc is a commercial-stage, autologous cellular therapeutic company that develops products for aesthetic, medical and scientific applications.

You can sell covered calls on FIBROCELL SCIENCE INC COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for FCSC (prices last updated Mon 4:16 PM ET):

FIBROCELL SCIENCE INC COMMON (FCSC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.76 -0.04 0.73 0.76 3.9M - 0.0B
Covered Calls For FIBROCELL SCIENCE INC COMMON (FCSC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 2.5 0.00 0.76 0.0% 0.0%
Jul 20 2.5 0.00 0.76 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Fibrocell Science, Inc. operates as a autologous cell therapy company, which focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company has a pipeline of therapeutic and aesthetic product development programs based on the first Food and Drug Administration approved cell-based product, LAVIV™ (azficel-T), in aesthetics, all of which are based on the autologous fibroblast cell. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. Fibrocell Science was founded on September 1, 2009 and is headquartered in Exton, PA.